297 related articles for article (PubMed ID: 15553066)
1. [Treatment strategies of acute and chronic hepatitis C].
Gładysz A; Inglot M
Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial results of peginterferons in combination with ribavirin.
Craxi A; Licata A
Semin Liver Dis; 2003; 23 Suppl 1():35-46. PubMed ID: 12934167
[TBL] [Abstract][Full Text] [Related]
3. [Genotype 1 superresponder treat for only 24 weeks].
MMW Fortschr Med; 2005 Dec; 147(51-52):69. PubMed ID: 16402717
[No Abstract] [Full Text] [Related]
4. [Primer treatment of acute and chronic hepatitis C].
Daruich J; Fainboim H; Frider B
Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
[No Abstract] [Full Text] [Related]
5. Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
Dusheiko G; Danta M
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):130-1. PubMed ID: 16265150
[No Abstract] [Full Text] [Related]
6. The treatment of viral hepatitis, present and future.
Rodés J
J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
[No Abstract] [Full Text] [Related]
7. Treating hepatitis C: are children the same as adults?
Delgado-Borrego A
Gastroenterology; 2011 Feb; 140(2):389-92. PubMed ID: 21172331
[No Abstract] [Full Text] [Related]
8. [Treatment of hepatitis C virus infection].
Zeuzem S
Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
[TBL] [Abstract][Full Text] [Related]
9. Interferon for hepatitis C patients with psychiatric disorders.
Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
[No Abstract] [Full Text] [Related]
10. Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy.
Jacobson IM
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):921-30. PubMed ID: 19362605
[No Abstract] [Full Text] [Related]
11. Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C.
Camerini R; Ciancio A; DE Rosa A; Rizzetto M
Ann N Y Acad Sci; 2007 Sep; 1112():368-74. PubMed ID: 17600286
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
13. Peginterferon and ribavirin for hepatitis C.
Abramowicz M
N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
[No Abstract] [Full Text] [Related]
14. Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".
Baiocchi L; Lenci I; Carbone M; Angelico M
Hepatology; 2009 Nov; 50(5):1676-7. PubMed ID: 19876945
[No Abstract] [Full Text] [Related]
15. [Eliminating the gray zone. What can be done in normal ALT values?].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():75. PubMed ID: 15373059
[No Abstract] [Full Text] [Related]
16. Interferon for hepatitis C patients with psychiatric disorders.
Rifai MA; Bozorg B; Rosenstein DL
Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
[No Abstract] [Full Text] [Related]
17. Pegylated IFNs for chronic hepatitis C: an update.
Grace MJ; Cutler DL; Bordens RW
Expert Opin Drug Deliv; 2005 Mar; 2(2):219-26. PubMed ID: 16296749
[TBL] [Abstract][Full Text] [Related]
18. A success story with chronic hepatitis C.
Weekley D; Yuen JC
J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
[No Abstract] [Full Text] [Related]
19. Digestive Disease Week 2000 conference report: New treatments for chronic hepatitis C.
Brown PJ; Neuman MG
Can J Clin Pharmacol; 2001; 8(2):67-71. PubMed ID: 11493933
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.
Taffaro M; Pyrsopoulos N; Cedron H; Cacayorin E; Weppler D; Moon J; Nishida S; Levi D; Kato T; Selvaggi G; Tzakis A; Schiff E
Dig Dis Sci; 2007 Dec; 52(12):3435-7. PubMed ID: 17431776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
